Organon & Co. Statistics
Total Valuation
Organon & Co. has a market cap or net worth of $3.64 billion. The enterprise value is $10.74 billion.
| Market Cap | 3.64B |
| Enterprise Value | 10.74B |
Important Dates
The last earnings date was Friday, October 30, 2026, before market open.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | Nov 9, 2026 |
Share Statistics
Organon & Co. has 262.62 million shares outstanding. The number of shares has increased by 2.43% in one year.
| Current Share Class | 262.62M |
| Shares Outstanding | 262.62M |
| Shares Change (YoY) | +2.43% |
| Shares Change (QoQ) | +0.72% |
| Owned by Insiders (%) | 0.47% |
| Owned by Institutions (%) | 77.48% |
| Float | 243.06M |
Valuation Ratios
The trailing PE ratio is 17.12 and the forward PE ratio is 3.84.
| PE Ratio | 17.12 |
| Forward PE | 3.84 |
| PS Ratio | 0.60 |
| Forward PS | 0.58 |
| PB Ratio | 3.05 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.39 |
| P/OCF Ratio | 4.31 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.93, with an EV/FCF ratio of 15.91.
| EV / Earnings | 50.41 |
| EV / Sales | 1.76 |
| EV / EBITDA | 6.93 |
| EV / EBIT | 8.91 |
| EV / FCF | 15.91 |
Financial Position
The company has a current ratio of 2.02, with a Debt / Equity ratio of 7.17.
| Current Ratio | 2.02 |
| Quick Ratio | 1.11 |
| Debt / Equity | 7.17 |
| Debt / EBITDA | 5.28 |
| Debt / FCF | 12.67 |
| Interest Coverage | 2.70 |
Financial Efficiency
Return on equity (ROE) is 20.30% and return on invested capital (ROIC) is 6.10%.
| Return on Equity (ROE) | 20.30% |
| Return on Assets (ROA) | 5.59% |
| Return on Invested Capital (ROIC) | 6.10% |
| Return on Capital Employed (ROCE) | 11.21% |
| Weighted Average Cost of Capital (WACC) | 5.35% |
| Revenue Per Employee | $609,900 |
| Profits Per Employee | $21,300 |
| Employee Count | 10,000 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 1.99 |
Taxes
In the past 12 months, Organon & Co. has paid $290.00 million in taxes.
| Income Tax | 290.00M |
| Effective Tax Rate | 57.65% |
Stock Price Statistics
The stock price has increased by +106.48% in the last 52 weeks. The beta is 1.54, so Organon & Co.'s price volatility has been higher than the market average.
| Beta (5Y) | 1.54 |
| 52-Week Price Change | +106.48% |
| 50-Day Moving Average | 13.74 |
| 200-Day Moving Average | 11.59 |
| Relative Strength Index (RSI) | 67.35 |
| Average Volume (20 Days) | 2,245,894 |
Short Selling Information
The latest short interest is 18.82 million, so 7.17% of the outstanding shares have been sold short.
| Short Interest | 18.82M |
| Short Previous Month | 17.53M |
| Short % of Shares Out | 7.17% |
| Short % of Float | 7.74% |
| Short Ratio (days to cover) | 8.54 |
Income Statement
In the last 12 months, Organon & Co. had revenue of $6.10 billion and earned $213.00 million in profits. Earnings per share was $0.81.
| Revenue | 6.10B |
| Gross Profit | 3.27B |
| Operating Income | 1.21B |
| Pretax Income | 503.00M |
| Net Income | 213.00M |
| EBITDA | 1.55B |
| EBIT | 1.21B |
| Earnings Per Share (EPS) | $0.81 |
Balance Sheet
The company has $1.46 billion in cash and $8.55 billion in debt, with a net cash position of -$7.10 billion or -$27.03 per share.
| Cash & Cash Equivalents | 1.46B |
| Total Debt | 8.55B |
| Net Cash | -7.10B |
| Net Cash Per Share | -$27.03 |
| Equity (Book Value) | 1.19B |
| Book Value Per Share | 4.54 |
| Working Capital | 2.72B |
Cash Flow
In the last 12 months, operating cash flow was $843.00 million and capital expenditures -$168.00 million, giving a free cash flow of $675.00 million.
| Operating Cash Flow | 843.00M |
| Capital Expenditures | -168.00M |
| Depreciation & Amortization | 344.00M |
| Net Borrowing | -214.00M |
| Free Cash Flow | 675.00M |
| FCF Per Share | $2.57 |
Margins
Gross margin is 53.65%, with operating and profit margins of 19.76% and 3.49%.
| Gross Margin | 53.65% |
| Operating Margin | 19.76% |
| Pretax Margin | 8.25% |
| Profit Margin | 3.49% |
| EBITDA Margin | 25.40% |
| EBIT Margin | 19.76% |
| FCF Margin | 11.07% |
Dividends & Yields
This stock pays an annual dividend of $0.08, which amounts to a dividend yield of 0.58%.
| Dividend Per Share | $0.08 |
| Dividend Yield | 0.58% |
| Dividend Growth (YoY) | -76.47% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 9.89% |
| FCF Payout Ratio | 3.11% |
| Buyback Yield | -2.43% |
| Shareholder Yield | -1.85% |
| Earnings Yield | 5.84% |
| FCF Yield | 18.56% |
Analyst Forecast
The average price target for Organon & Co. is $10.33, which is -25.44% lower than the current price. The consensus rating is "Hold".
| Price Target | $10.33 |
| Price Target Difference | -25.44% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 1.16% |
| EPS Growth Forecast (3Y) | 1.74% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Organon & Co. has an Altman Z-Score of 1.29 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.29 |
| Piotroski F-Score | 6 |